ERVW-1 and ovarian cancer: In vivo, in the intraperitoneal xenograft SKOV-3-Fluc ovarian cancer model, a single intraperitoneal injection of oFV and oFV-GFP potently controlled tumor growth, possibly due to the fusogenic properties of the oFV Env protein.